{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:22:40Z","timestamp":1769973760345,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.pep.2021.105947","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T08:06:46Z","timestamp":1627114006000},"page":"105947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Structural exploration of Y-domain reveals its essentiality in HEV pathogenesis"],"prefix":"10.1016","volume":"187","author":[{"given":"Zoya","family":"Shafat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-1442","authenticated-orcid":false,"given":"Abu","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asimul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed S.","family":"Al-Dosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad K.","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shama","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pep.2021.105947_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jvh.12445","article-title":"Hepatitis E: an emerging global disease\u2013from discovery towards control and cure","volume":"23","author":"Khuroo","year":"2016","journal-title":"J. Viral Hepat."},{"issue":"4","key":"10.1016\/j.pep.2021.105947_bib2","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1128\/JCM.02002-09","article-title":"Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation","volume":"48","author":"Takahashi","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib3","first-page":"41","article-title":"Zoonotic and foodborne transmission of hepatitis E virus","volume":"33","author":"Meng","year":"2013"},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0042-6822(91)90760-9","article-title":"Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome","volume":"185","author":"Tam","year":"1991","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib5","doi-asserted-by":"crossref","first-page":"a031724","DOI":"10.1101\/cshperspect.a031724","article-title":"Hepatitis E virus genome structure and replication strategy","volume":"9","author":"Kenney","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.pep.2021.105947_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1096-9071(200003)60:3<275::AID-JMV5>3.0.CO;2-9","article-title":"Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1)","volume":"60","author":"Ansari","year":"2000","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.pep.2021.105947_bib7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s007050070093","article-title":"Expression of the hepatitis E virus ORF1","volume":"145","author":"Ropp","year":"2000","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1743-422X-8-245","article-title":"Lack of processing of the expressed ORF1 gene product of hepatitis E virus","volume":"8","author":"Suppiah","year":"2011","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.pep.2021.105947_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3748\/wjg.v23.i4.590","article-title":"Mutational analysis of hepatitis E virus ORF1\u201cY-domain\u201d: Effects on RNA replication and virion infectivity","volume":"23","author":"Parvez","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.pep.2021.105947_bib10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","article-title":"The development of a recombinant hepatitis E vaccine HEV 239","volume":"11","author":"Li","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.pep.2021.105947_bib11","series-title":"Protein Identification and Analysis Tools on the ExPASy Server. InThe Proteomics Protocols Handbook","first-page":"571","author":"Gasteiger","year":"2005"},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.pep.2021.105947_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/jmbi.1999.3091","article-title":"Protein secondary structure prediction based on position-specific scoring matrices","volume":"292","author":"Jones","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pep.2021.105947_bib14","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-based virtual screening for drug discovery: principles, applications and recent advances","volume":"14","author":"Lionta","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pep.2021.105947_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/acs.jcim.8b00363","article-title":"Practical model selection for prospective virtual screening","volume":"59","author":"Liu","year":"2018","journal-title":"J. Chem. Inf. Model."},{"issue":"D1","key":"10.1016\/j.pep.2021.105947_bib16","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(02)00185-7","article-title":"Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses","volume":"58","author":"Crance","year":"2003","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib18","first-page":"1","article-title":"Inhibition of influenza A virus infection by fucoidan targeting viral neuraminidase and cellular EGFR pathway","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pep.2021.105947_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/fvl.10.81","article-title":"Taribavirin: potential future in the treatment of hepatitis C","volume":"6","author":"Farrell","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.pep.2021.105947_bib20","first-page":"198","article-title":"Bene\ufb01cial health effects of lupenone triterpene: a review","volume":"103","author":"Xu","year":"2018","journal-title":"Biomedicine"},{"issue":"5","key":"10.1016\/j.pep.2021.105947_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/14786410310001605841","article-title":"Evaluation of the antiviral and antimicrobial activities of triterpenes isolated from Euphorbia segetalis","volume":"17","author":"Madureira","year":"2003","journal-title":"Nat. Prod. Res."},{"issue":"5","key":"10.1016\/j.pep.2021.105947_bib22","doi-asserted-by":"crossref","first-page":"E811","DOI":"10.1073\/pnas.1619114114","article-title":"Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor","volume":"114","author":"Kuhlmann","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.pep.2021.105947_bib23","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.pep.2021.105947_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.pep.2021.105947_bib25","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1099\/jgv.0.000512","article-title":"Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans","volume":"97","author":"To","year":"2016","journal-title":"J. Gen. Virol."},{"issue":"7","key":"10.1016\/j.pep.2021.105947_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"2","key":"10.1016\/j.pep.2021.105947_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"2","key":"10.1016\/j.pep.2021.105947_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"1\u20133","key":"10.1016\/j.pep.2021.105947_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2105-13-173","article-title":"Defining and searching for structural motifs using DeepView\/Swiss-PdbViewer","volume":"13","author":"Johansson","year":"2012","journal-title":"BMC Bioinf."},{"issue":"5","key":"10.1016\/j.pep.2021.105947_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.pep.2021.105947_bib32","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"issue":"2","key":"10.1016\/j.pep.2021.105947_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng. Des. Sel."},{"issue":"24","key":"10.1016\/j.pep.2021.105947_bib34","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1016\/j.bmcl.2011.10.057","article-title":"Molecular properties prediction and synthesis of novel 1, 3, 4-oxadiazole analogues as potent antimicrobial and antitubercular agents","volume":"21","author":"Ahsan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.pep.2021.105947_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092064","article-title":"Discovery of novel ligands for mouse olfactory receptor MOR42-3 using an in silico screening approach and in vitro validation","volume":"9","author":"Bavan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pep.2021.105947_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1743-422X-3-38","article-title":"Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein","volume":"3","author":"Sehgal","year":"2006","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.genet.30.1.465","article-title":"Proteases and their targets in Escherichia coli","volume":"30","author":"Gottesman","year":"1996","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.pep.2021.105947_bib38","first-page":"118","volume":"vol. 17","author":"Rizkia","year":"2015"},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib39","article-title":"Effect of IPTG concentration on recombinant human prethrombin-2 expression in Escherichia coli BL21 (DE3) ArcticExpress","volume":"217","author":"Silaban","year":"2018"},{"issue":"3","key":"10.1016\/j.pep.2021.105947_bib40","first-page":"563","article-title":"Maximizing production of human interferon-\u03b3 in HCDC of recombinant E. coli","volume":"12","author":"Babaeipour","year":"2013","journal-title":"Iran. J. Pharm. Res. (IJPR): IJPR"},{"key":"10.1016\/j.pep.2021.105947_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pep.2017.10.012","article-title":"Efficient solubilization and purification of highly insoluble membrane proteins expressed as inclusion bodies using perfluorooctanoic acid","volume":"143","author":"Plucinsky","year":"2018","journal-title":"Protein Expr. Purif."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1046-5928(02)00641-1","article-title":"Practical considerations in refolding proteins from inclusion bodies","volume":"28","author":"Tsumoto","year":"2003","journal-title":"Protein Expr. Purif."},{"issue":"6","key":"10.1016\/j.pep.2021.105947_bib43","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.3390\/v7062747","article-title":"Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis","volume":"7","author":"Boulant","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.pep.2021.105947_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pep.2021.105947_bib45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"issue":"11","key":"10.1016\/j.pep.2021.105947_bib46","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.32.11.1742","article-title":"Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus","volume":"32","author":"Baba","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13062-015-0050-0","article-title":"Sequence analysis reveals a conserved extension in the capping enzyme of the alphavirus supergroup, and a homologous domain in nodaviruses","volume":"10","author":"Ahola","year":"2015","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2212 a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"issue":"17","key":"10.1016\/j.pep.2021.105947_bib50","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JB.180.17.4704-4710.1998","article-title":"Effect of temperature on in vivo protein synthetic capacity in Escherichia coli","volume":"180","author":"Farewell","year":"1998","journal-title":"J. Bacteriol."},{"issue":"1","key":"10.1016\/j.pep.2021.105947_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.1977.tb21977.x","article-title":"Antiviral action and selectivity of 6\u2010azauridine","volume":"284","author":"Rada","year":"1977","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.pep.2021.105947_bib52","first-page":"183","article-title":"Highly active antiviral and immunosuppressive combination therapy with acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease","volume":"218","author":"Reisr","year":"2001","journal-title":"Klin. Monatsbl\u00e4tter Augenheilkd."},{"issue":"9","key":"10.1016\/j.pep.2021.105947_bib53","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/v12091041","article-title":"Identification of inhibitors of ZIKV replication","volume":"12","author":"Morales Vasquez","year":"2020","journal-title":"Viruses"}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592821001303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592821001303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:55:51Z","timestamp":1760925351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592821001303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":52,"alternative-id":["S1046592821001303"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2021.105947","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural exploration of Y-domain reveals its essentiality in HEV pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2021.105947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105947"}}